“It’s the first targeted personalized medicine that had ever been used.”
"Everyone hopes and wishes for that last-minute cancer breakthrough that will save doomed patients. It almost never actually happens. With Gleevec, it did.
The once-a-day pill turned chronic myelogenous leukemia, or CML, from a certain death sentence into a manageable disease. Now data shows it's helped 83 percent of patients live 10 years or longer, even with side-effects that include a characteristic rash, nausea and fatigue."
Call in to hear the incredible story of imatinib from Dr. Drucker himself at our Interactive Session on 3/22! lnk.al/3VTz
Please join us on March 22, 2017 at 5:00pm EDT. Join the webinar online or dial in to participate:
Webinar URL: global.gotomeeting.com/join/18...
Dial In Information:
United States: +1 (872) 240-3412
Access Code: 182-533-19
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.